Results 181 to 190 of about 73,182 (298)

Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis? [PDF]

Arch Rheumatol
Koçak Ulucaköy R, Kılıç A, Batıbay S, Çobanoğlu İM, Yıldırım Öztürk EN, Günendi Z, Sepici Dinçel A, Göğüş FN.   +7 more
europepmc   +1 more source

A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide. [PDF]

Front Oncol, 2022
Bota DA, Taylor TH, Lomeli N, Kong XT, Fu BD, Schönthal AH, Singer S, Blumenthal DT, Senecal FM, Linardou H, Rokas E, Antoniou DG, Schijns VEJC, Chen TC, Elliot J, Stathopoulos A.   +15 more
europepmc   +1 more source

Production of Granulocyte-Macrophage Colony-Stimulating Factors (GM-CSF) by Various Mammalian Cell Lines Cultured in a Protein-Free Synthetic Medium

, 1980
Kazuko Tsuneoka, Mikio Shikita
openalex   +2 more sources

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll‐Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double‐Blind, Placebo‐Controlled Study

ACR Open Rheumatology, Volume 7, Issue 7, July 2025.
Objective There is an unmet need for safe and effective oral treatments for cutaneous lupus erythematosus (CLE). Afimetoran is an investigational, first‐in‐class, orally bioavailable, selective small molecule inhibitor of Toll‐like receptors (TLRs) 7 and 8.
Fareeda Hosein, Stanislav Ignatenko, Kristina D. Chadwick, Lin Zhu, Frédéric Baribaud, Jasmine Saini, Thanh Bach, Urvi Aras, WanYing Zhang, Hazem Karabeber, Michelle Dawes, Melanie Harrison, Leonidas N. Carayannopoulos, Gopal Krishna   +13 more
wiley   +1 more source

Addition of granulocyte macrophage colony stimulating factor (GM-CSF) during in vitro oocyte maturation improves embryo development in a mouse model of advanced maternal age. [PDF]

J Reprod Dev
Saini A, McPherson NO, Nottle MB.
europepmc   +1 more source

Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. [PDF]

PLoS One, 2022
Karmacharya MB, Hada B, Park SR, Kim KH, Choi BH.   +4 more
europepmc   +1 more source

Modern Strategies in Wound Healing: The Rise of Bacterial Cellulose Dressings

Advanced Therapeutics, Volume 8, Issue 7, July 2025.
Bacterial cellulose (BC)‐based wound dressings combine high water retention, biocompatibility, and mechanical strength to support wound healing. This review highlights advanced functionalization strategies and fabrication techniques that enhance BC's therapeutic performance, establishing it as a promising material for next‐generation wound care ...
Elif Naz Gürsoy, Kubra Sener, M. Burcu Külahci, K. Barbaros Balabanli, Şule Coşkun Cevher   +4 more
wiley   +1 more source

Elevated Salt or Angiotensin II Levels Induce CD38+ Innate Immune Cells in the Presence of Granulocyte-Macrophage Colony Stimulating Factor. [PDF]

Cells
Smith HL, Goodlett BL, Navaneethabalakrishnan S, Mitchell BM.   +3 more
europepmc   +1 more source

[Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up]. [PDF]

Dermatologie (Heidelb), 2023
Jaschke E, Umlauft J, Palmer-Reichel K, Oberaigner W, Schmuth M.   +4 more
europepmc   +1 more source

Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer [PDF]

, 1994
Andrea Ardizzoni, M. Venturini, M.R. Sertoli, PG Giannessi, Fulvio Brema, Marco Danova, Franco Testore, G Mariani, MC Pennucci, Paola Queirolo, S Silvestro, Paolo Bruzzi, Rita Lionetto, Fabio Latini, R. Rosso   +14 more
openalex   +1 more source